BioNTech is a biotechnology company that develops personalised cancer medicine and other therapeutics based on groundbreaking research with cutting-edge technologies. As a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), BioNTech provides advanced manufacturing capabilities for biopharmaceutical products aimed at revolutionising treatment modalities within the pharmaceutical industry.

Services include:
- Development of personalised cancer vaccines
- Advanced mRNA manufacturing
- Cell and gene therapy production
- Bioprocess development and optimisation
- Quality control and analysis
- Regulatory support and compliance

With a commitment to innovation and excellence, BioNTech continuously seeks to enhance its offerings and contribute to the landscape of biotechnology. For further details, please visit biontech.de.